Articles published by Gilead Sciences, Inc.
![](https://mms.businesswire.com/media/20211014005206/en/778437/5/GCP_Primarylarge_%281%29.jpg)
Gilead Sciences to Release Third Quarter 2021 Financial Results on Thursday, October 28, 2021
October 14, 2021
Via Business Wire
Tickers
GILD
![](https://mms.businesswire.com/media/20211001005719/en/912357/4/5301808_US_Authorized_Treatment_Centers_for_CAR_T-Cell_Therapy_Map.jpg)
![](https://mms.businesswire.com/media/20210927005700/en/778437/5/GCP_Primarylarge_%281%29.jpg)
![](https://mms.businesswire.com/media/20210922005622/en/778437/5/GCP_Primarylarge_%281%29.jpg)
Veklury® (Remdesivir) Significantly Reduced Risk of Hospitalization in High-Risk Patients with COVID-19
September 22, 2021
Via Business Wire
Tickers
GILD
![](https://mms.businesswire.com/media/20210920005228/en/778437/5/GCP_Primarylarge_%281%29.jpg)
![](https://mms.businesswire.com/media/20210916005030/en/778437/5/GCP_Primarylarge_%281%29.jpg)
![](https://mms.businesswire.com/media/20210916005029/en/778437/5/GCP_Primarylarge_%281%29.jpg)
![](https://mms.businesswire.com/media/20210913005112/en/778437/5/GCP_Primarylarge_%281%29.jpg)
Gilead to Present New Data at ESMO Congress 2021 Reinforcing the Practice-changing Potential of Trodelvy
September 13, 2021
Via Business Wire
Tickers
GILD
![](https://mms.businesswire.com/media/20210901005966/en/778437/5/GCP_Primarylarge_%281%29.jpg)
Gilead Sciences to Present at Upcoming Investor Conference
September 01, 2021
Via Business Wire
Tickers
GILD
![](https://mms.businesswire.com/media/20210819005756/en/778437/5/GCP_Primarylarge_%281%29.jpg)
![](https://mms.businesswire.com/media/20210803005321/en/778437/5/GCP_Primarylarge_%281%29.jpg)
![](https://mms.businesswire.com/media/20210729005981/en/778437/5/GCP_Primarylarge_%281%29.jpg)
Via Business Wire
Tickers
GILD
![](https://mms.businesswire.com/media/20210719005385/en/892205/5/BioNTech_Logo.jpg)
![](https://mms.businesswire.com/media/20210717005010/en/778437/5/GCP_Primarylarge_%281%29.jpg)
![](https://mms.businesswire.com/media/20210717005011/en/778437/5/GCP_Primarylarge_%281%29.jpg)
![](https://mms.businesswire.com/media/20210715005809/en/778437/5/GCP_Primarylarge_%281%29.jpg)
Gilead Sciences to Release Second Quarter 2021 Financial Results on Thursday, July 29, 2021
July 15, 2021
Via Business Wire
Tickers
GILD
![](https://mms.businesswire.com/media/20210712005412/en/778437/5/GCP_Primarylarge_%281%29.jpg)
![](https://mms.businesswire.com/media/20210628005788/en/778437/5/GCP_Primarylarge_%281%29.jpg)
![](https://mms.businesswire.com/media/20210628005449/en/888077/5/Yescarta_Logo_Suspension_R_4c_highres.jpg)
![](https://mms.businesswire.com/media/20210624005563/en/778437/5/GCP_Primarylarge_%281%29.jpg)
![](https://mms.businesswire.com/media/20210623005554/en/836069/5/NEW_KITE_COLOR_LOGO.jpg)
Kite Joint Venture - Fosun Kite - Gains the First CAR T-cell Therapy Approval in China
June 23, 2021
Via Business Wire
Tickers
GILD
![](https://mms.businesswire.com/media/20210621005210/en/778437/5/GCP_Primarylarge_%281%29.jpg)
![](https://mms.businesswire.com/media/20210621005271/en/778437/5/GCP_Primarylarge_%281%29.jpg)
![](https://mms.businesswire.com/media/20210617005497/en/885964/5/Shoreline_logoHR.jpg)
![](https://mms.businesswire.com/media/20210610005958/en/778437/5/GCP_Primarylarge_%281%29.jpg)
![](https://mms.businesswire.com/media/20210604005067/en/882868/5/NEW_KITE_COLOR_LOGO.jpg)
![](https://mms.businesswire.com/media/20210604005059/en/778437/5/GCP_Primarylarge_%281%29.jpg)
![](https://mms.businesswire.com/media/20210519005762/en/879705/5/NEW_KITE_COLOR_LOGO.jpg)
Gilead-Kite Oncology to Present Transformative Science From Growing Portfolio at ASCO 2021
May 19, 2021
Via Business Wire
Tickers
GILD
![](https://mms.businesswire.com/media/20210514005524/en/778437/5/GCP_Primarylarge_%281%29.jpg)
Via Business Wire
Tickers
GILD
![](https://mms.businesswire.com/media/20210506006218/en/778437/5/GCP_Primarylarge_%281%29.jpg)
Via Business Wire
Tickers
GILD
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.